[{"Assets_0_FY_USD":5123672000.0,"CommonStockSharesOutstanding_0_FY_shares":59898000.0,"EarningsPerShareBasic_1_FY_USD":3.87,"EarningsPerShareBasic_4_FY_USD":8.13,"EarningsPerShareDiluted_1_FY_USD":3.79,"EarningsPerShareDiluted_4_FY_USD":7.96,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":693087000.0,"NetIncomeLoss_1_FY_USD":232207000.0,"NetIncomeLoss_4_FY_USD":487848000.0,"StockholdersEquity_0_FY_USD":2713097000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":61317000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":60018000.0,"Ticker":"JAZZ","CIK":"1232524","name":"JAZZ PHARMACEUTICALS PLC","OfficialName":"Jazz Pharmaceuticals plc Common Stock (Ireland)","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"10281986580.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180227"}]